Proteome Sciences (AIM:PRM) - leading the way in diagnosis and disease monitoring
With a growing demand for personalised medicine, the proteomics market has taken off substantially over the past few years. The work by Proteome Sciences focuses specifically on Biomarkers, Biomarker Assays and Isobaric and Isotopic Reagents, alongside the offering of Biomarker Services. The company have successfully established an IP portfolio of biomarkers associated with a range of diseases, as well as a patented tagging technology ‘Tandem Mass Tag®’ (TMT®), which can assist in the measurement of…
Previous article Next article